HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TOKUNAGA, Norihito, NAKAMURA, Shinji, TAKAMI, Kazuaki, TAKASHIMA, Sachie, KAMEI, Taku, AIDA, Jumpei, IWANAGA, Kouichi, YAMAMOTO, Satoshi, NAKAMURA, Minoru, DAINI, Masaki, SETO, Masaki, KAMATA, Makoto, WADA, Yasufumi, WAKABAYASHI, Takeshi, MIKAMI, Satoshi, MURAKAMI, Masataka, KAKEI, Hiroyuki, TAWARAISHI, Taisuke, MATSUMOTO, Shigemitsu, OGURO, Yuya, ITO, Mitsuhiro, MORIMOTO, Shinji
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like.The present invention relates to a compound represented by the formula (I):wherein each symbol is as described in the description, or a salt thereof.